CAMPBELL BRADLEY L (President and CEO) sold 2.2% of their position (22.50K shares) of AMICUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $322.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001193125-26-092114
DirectorOfficer· President and CEO
Since Mar 2026
-22.50K
Net shares
Net seller
$322.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
22.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−22.50K
Price / share
$14.35
Trade value
$322.84K
% of position
2.2%
3/2/2026
1.02M→998.68K
Total
Net shares
−22.50K
Net value
-$322.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −22.50K | $14.35 | $322.84K | 2.2% | 1.02M | 998.68K |
| Total | −22.50K | -$322.84K | ||||||
Derivative Transactions0
No derivative transactions reported